CCCC C4 Therapeutics Inc

USD 1.23 -0.01 ( -0.81%)
Icon

C4 Therapeutics Inc (CCCC) Stock Analyst Ratings & Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.23

-0.01 (-0.81%)

N/A

1.42M

USD 9.50(+672.36%)

USD 5.67 (+360.98%)

Icon

CCCC

C4 Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 1.23
-0.01 ( -0.81%)

C4 Therapeutics Inc (CCCC) Stock Forecast

Show ratings and price targets of :
USD 9.50
(+672.36%)

Based on the C4 Therapeutics Inc stock forecast from 4 analysts, the average analyst target price for C4 Therapeutics Inc is USD 9.50 over the next 12 months. C4 Therapeutics Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of C4 Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, C4 Therapeutics Inc’s stock price was USD 1.23. C4 Therapeutics Inc’s stock price has changed by -7.52% over the past week, -39.41% over the past month and -83.40% over the last year.

Analyst Ratings

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...